2012 | Aarkstore.com || Respiratory depression – pipeline review, h2 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Respiratory Depression – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Respiratory Depression - Pipeline Review, H2 2012,
provides an overview of the indication’s therapeutic pipeline. This report provides
information on the therapeutic development for Respiratory Depression, complete
with latest updates, and special features on late-stage and discontinued projects. It
also reviews key players involved in the therapeutic development for Respiratory
Depression. Respiratory Depression - Pipeline Review, Half Year is built using data
and information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Respiratory Depression.
- A review of the Respiratory Depression products under development by
companies and universities/research institutes based on information derived from

2. company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Respiratory Depression.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Respiratory Depression Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Respiratory Depression 7
Respiratory Depression Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Discovery and Pre-Clinical Stage Products 12
Comparative Analysis 12
Respiratory Depression Therapeutics – Products under Development by Companies
13
Companies Involved in Respiratory Depression Therapeutics Development 14
Cortex Pharmaceuticals, Inc. 14
Galleon Pharmaceuticals 15
Sihuan Pharmaceutical Holdings Group Ltd. 16
Respiratory Depression – Therapeutics Assessment 17
Assessment by Monotherapy Products 17

3. Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012
Respiratory Depression – Pipeline Review, H2 2012
Metastatic Cancer – Pipeline Review, H2 2012
Viral Infections – Pipeline Review, H2 2012
Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
Gastrointestinal Tract Cancer – Pipeline Review, H2 2012
Diabetes – Pipeline Review, H2 2012
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,

4. H2 2012
Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
Malaria – Pipeline Review, H2 2012
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012
Dermatitis – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com